Legend Biotech/LEGN

$67.40

-3.7%
-
1D1W1MYTD1YMAX

About Legend Biotech

Legend Biotech Corporation is a global biotechnology company, which is focused on developing, manufacturing and commercializing novel therapies to treat life-threatening diseases. The Company is developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), is a CAR-T cell therapy for the treatment of multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also developing an allogeneic gamma delta CAR-T product candidate targeting B-cell maturation antigen for MM.

Ticker

LEGN

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Fangliang Zhang

Employees

1,390

Headquarters

Somerset, United States

Legend Biotech Metrics

BasicAdvanced
$12.18B
Market cap
-
P/E ratio
-
EPS
0.04
Beta
-
Dividend rate

What the Analysts think about Legend Biotech

Analyst Ratings

Majority rating from 19 analysts.
Buy

Price Targets

Average projection from 15 analysts.
28.03% upside
High $100.00
Low $65.00
$67.40
Current price
$86.29
Average price target

Legend Biotech Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-64.79% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$96M
30.97%
Net income
$-62.2M
-68.76%
Profit margin
-64.79%
-76.15%

Legend Biotech Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 49.82%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-
-$0.68
-$1.14
-$0.34
-
Expected
-$0.42
-$0.78
-$0.60
-$0.68
-$0.61
Surprise
-
-12.82%
90%
-49.82%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
ADR

Upcoming events

Buy or sell Legend Biotech stock

Buy or sell Legend Biotech stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing